Biogen
Biotechnology company focused on neurology, including multiple sclerosis and rare neurogenetic diseases.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Immunoglobulin A Nephropathy (IgAN)
A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's AtaxiaPhase 3 · Recruiting · Friedreich Ataxia
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With RisdiplamPhase 3 · Recruiting · Spinal Muscular Atrophy
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)Phase 3 · Recruiting · Muscular Atrophy, Spinal
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene AbeparvovecPhase 3 · Recruiting · Muscular Atrophy, Spinal
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)Phase 3 · Recruiting · Primary Membranous Nephropathy
Selected patent records
nusinersen sodium · Expires 2027-07-11
US 8399514dimethyl fumarate · Expires 2028-02-07
US 9717750nusinersen sodium · Expires 2030-06-17
US 8980853nusinersen sodium · Expires 2030-11-24
US 8361977nusinersen sodium · Expires 2030-12-23
US 9926559nusinersen sodium · Expires 2034-01-09
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/biogen/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.